If you have breast cancer, your doctor may prescribe Aromasin for you. It’s a prescription drug that’s used in females* who have gone through menopause. Aromasin is used to treat the following in ...

CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on ...

Aromasin was approved in late in 1999 for the treatment of advanced breast cancer in postmenopausal women whose tumours have stopped responding to tamoxifen. For the first quarter of this year, the ...

Aromatase inhibitors cause unwanted side effects. More and more women are choosing not to take them, but is this a good idea? The decision to walk away from taking aromatase inhibitors is a choice ...

Exemestane (Aromasin) is an aromatase inhibitor, prescribed for advanced breast cancer in postmenopausal women who are no longer responsive to anti-estrogen therapy.It works by decreasing the amount ...

The role of maintenance bevacizumab in patients with metastatic breast cancer treated with chemotherapy and bevacizumab upon achieving complete response or maximal radiologic response with stable ...

Aromasin (exemestane) provides alternative option for postmenopausal women in breast cancer prevention. The highest risk factor for breast cancer is age, especially after 60 and after menopause, which ...

PEAPACK, N.J. — Greenstone has introduced an authorized generic treatment for breast cancer, the generics subsidiary of Pfizer said. The company announced the launch of exemestane tablets, an ...

A combination of Novartis' Afinitor and Pfizer's Aromasin failed to reach statistical significance in a trial’s secondary endpoint of overall survival. A combination of Novartis’ Afinitor and Pfizer’s ...

New Delhi: Drug major Cipla has received final approval from the US health regulator for generic equivalent of Avadel's Vazculep, West Ward Pharm Corp's Phenylephrine Hydrochloride injection and ...